Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marc, Evanchik"'
Autor:
Man-Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan T. Nguyen, Eugene R. Schiff, Hie-Won L. Hann, Douglas T. Dieterich, Ronald G. Nahass, James S. Park, Sing Chan, Steven-Huy B. Han, Edward J. Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard Colonno, Julie Ma, Steven J. Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Yien Kwo, Magdy Elkhashab, Tarek Hassanein, Ho S. Bae, Jacob P. Lalezari, Scott K. Fung, Mark S. Sulkowski
Publikováno v:
Journal of Hepatology. 77:642-652
HBV nucleos(t)ide reverse transcriptase inhibitors (NrtIs) do not completely suppress HBV replication. Previous reports indicate persistent viremia during NrtI treatment despite HBV DNA being undetectable. HBV core inhibitors may enhance viral suppre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7a77f9cac5a69525b2790e5ecdf2d1
https://doi.org/10.1016/j.jhep.2022.04.005
https://doi.org/10.1016/j.jhep.2022.04.005
Autor:
Kosh Agarwal, Jia Xu, Edward J. Gane, Tuan T. Nguyen, Yanhua Ding, Steven J. Knox, Katia Alves, Marc Evanchik, Katie Zomorodi, Julie Ma, Ran Yan, Qi Huang, Richard Colonno, Luisa M. Stamm, Tarek I. Hassanein, Dong Joon Kim, Young‐Suk Lim, Man‐Fung Yuen
Publikováno v:
Journal of viral hepatitis.
Treatment for chronic hepatitis B virus infection (cHBV) is mostly indefinite, with new finite-duration therapies needed. We report safety, pharmacokinetics, and antiviral activity of the investigational HBV core inhibitor ABI-H2158. This Phase 1a/b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b300678d051e92f1cdcef6026169618e
https://pubmed.ncbi.nlm.nih.gov/36302125
https://pubmed.ncbi.nlm.nih.gov/36302125
Autor:
Mark P. Grillo, Svetlana Markova, Marc Evanchik, Marc Trellu, Patricia Moliner, Priscilla Brun, Anne Perreard-Dumaine, Pascale Vicat, Chun Yang, James P. Driscoll, Tim J. Carlson
Publikováno v:
Xenobiotica. 51:222-238
Dilated cardiomyopathy (DCM) is a disease of the myocardium defined by left ventricular enlargement and systolic dysfunction leading to heart failure. Danicamtiv, a new targeted myosin activator de...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e1361f51b200ee3d2f156a0c2ce1187
https://doi.org/10.1080/00498254.2020.1839982
https://doi.org/10.1080/00498254.2020.1839982
Autor:
Joanna Kaplan, Sarah Lehman, Mike Duvall, Molly Madden, Jessica Tolley, Natalie Hawryluk, Stephen Schlachter, Victor Rivas, Carina Jauregui, Amanda Crofton, Samantha Harris, Joshua Aaron Stern, Carlos L. del Rio, Alan Russell, Marc Evanchik
Publikováno v:
Journal of the American College of Cardiology. 81:349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b368cf0878b1b100daf88e5bfb60317
https://doi.org/10.1016/s0735-1097(23)00793-3
https://doi.org/10.1016/s0735-1097(23)00793-3
Autor:
Mark S. Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan T. Nguyen, Eugene R. Schiff, Hie-Won L. Hann, Douglas T. Dieterich, Ronald G. Nahass, James S. Park, Sing Chan, Steven-Huy B. Han, Edward J. Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard Colonno, Julie Ma, Steven J. Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Yien Kwo, Magdy Elkhashab, Tarek Hassanein, Ho S. Bae, Jacob P. Lalezari, Scott K. Fung, Man-Fung Yuen
Publikováno v:
Journal of hepatology. 77(5)
Nucleos(t)ide reverse transcriptase inhibitors do not completely suppress HBV DNA in chronic HBV infection (cHBV). Vebicorvir (VBR) is an investigational core inhibitor that interferes with multiple aspects of HBV replication. This phase II trial eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b1959f900369042b7add8624579b93
https://pubmed.ncbi.nlm.nih.gov/35697332
https://pubmed.ncbi.nlm.nih.gov/35697332
Autor:
Breanne Stamper, Sarah Lehman, Molly Madden, Mike DuVall, Ying Qian, Marc Evanchik, Ben Barthel, Carlos L. del Rio, Alan J. Russell
Publikováno v:
Biophysical Journal. 121:515a-516a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60b9503ff4dd7cfee609a27af9f73b7c
https://doi.org/10.1016/j.bpj.2021.11.2716
https://doi.org/10.1016/j.bpj.2021.11.2716
Autor:
Mark P, Grillo, Svetlana, Markova, Marc, Evanchik, Marc, Trellu, Patricia, Moliner, Priscilla, Brun, Anne, Perreard-Dumaine, Pascale, Vicat, James P, Driscoll, Tim J, Carlson
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 51(2)
Dilated cardiomyopathy (DCM) is a disease of the myocardium defined by left ventricular enlargement and systolic dysfunction leading to heart failure. Danicamtiv, a new targeted myosin activator designed for the treatment of DCM, was characterised in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63a8a54159ce8826d017fcbd171c2378
https://pubmed.ncbi.nlm.nih.gov/33078965
https://pubmed.ncbi.nlm.nih.gov/33078965